Puma Biotechnology, Inc.
PBYI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401667
In the last 90 days, Puma Biotechnology, Inc. insiders filed 0 open-market purchases and 5 sales; 160 institutions reported holding it in 13F filings for Q2 2026, worth $313.6M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Puma Biotechnology, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 104
- +3 vs. Q4 2021
- Shares held
- 29.9M
- −278.0K (−0.9%) vs. Q4 2021
- Total value
- $86.1M
- −$5.81M (−6.3%) vs. Q4 2021
- New holders
- 20
- 26 more added
- Sold out
- 17
- 41 more reduced
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PBYI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 160 | $313.6M |
| Q1 2026 | 157 | $241.8M |
| Q4 2025 | 151 | $210.2M |
| Q3 2025 | 132 | $182.6M |
| Q2 2025 | 121 | $112.8M |
| Q1 2025 | 116 | $90.1M |
| Q4 2024 | 112 | $90.1M |
| Q3 2024 | 100 | $76.0M |
| Q2 2024 | 99 | $101.0M |
| Q1 2024 | 93 | $164.4M |
| Q4 2023 | 82 | $117.0M |
| Q3 2023 | 69 | $67.6M |
| Q2 2023 | 68 | $93.8M |
| Q1 2023 | 78 | $86.3M |
| Q4 2022 | 89 | $116.3M |
| Q3 2022 | 83 | $65.5M |
| Q2 2022 | 89 | $79.5M |
| Q1 2022 | 104 | $86.1M |
| Q4 2021 | 102 | $93.1M |
| Q3 2021 | 116 | $226.0M |
| Q2 2021 | 120 | $319.3M |
| Q1 2021 | 118 | $355.9M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Puma Biotechnology, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Millennium Management LLC | 1,911,675 | $5.51M | 0.01% | +204,121+12.0% | Added |
| BlackRock Inc. | 3,379,684 | $9.73M | 0.00% | +175,447+5.5% | Added |
| Vanguard Group Inc | 3,466,840 | $9.98M | 0.00% | −213,347−5.8% | Reduced |
| Camber Capital Management LP | 4,000,000 | $11.5M | 0.42% | +1,950,000+95.1% | Added |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −756,675−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −557,538−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −396,967−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −105,103−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −101,947−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −80,077−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −78,512−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −38,201−100.0% | Sold out |
| Zebra Capital Management LLC | 0 | $0 | 0.00% | −25,058−100.0% | Sold out |
| Pinnacle Wealth Planning Services, Inc. | 0 | $0 | 0.00% | −16,749−100.0% | Sold out |
| Manteio Capital LLC | 0 | $0 | 0.00% | −16,409−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −11,847−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −4,789−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −1,429−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −586−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| KRS Capital Management, LLC | 0 | $0 | 0.00% | −58−100.0% | Sold out |
| AlphaCentric Advisors LLC | – | – | – | – | Not filed |